ARCHIVES

Seattle Institutions Win $16 Million In Grants For Comparative Effectiveness Research

This article is from The Cancer Letter archive.

Vol. 35 No. 38 | October 16, 2009

Download PDF Visit The Full Archive

Related Articles

Arimidex Gets Full Approval For HR+ Early Breast Cancer

September 30, 2005

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

July 3, 1981

June issue of Business & Regulatory Report included.

July 2, 2004

Another Feasibility Study For Women’s Wealth Trial? Yes And No; It’s ‘Class Of 84’s” Adieu

December 14, 1990

Blacks Less Likely To Receive Standard Radiation Therapy

October 31, 2008

Wistar’s Koprowski; Rivera Is Director

April 12, 1991